167 related articles for article (PubMed ID: 34028815)
1. Immunological role of keratinocytes in leishmaniasis.
Jafarzadeh A; Nair A; Jafarzadeh S; Nemati M; Sharifi I; Saha B
Parasite Immunol; 2021 Sep; 43(9):e12870. PubMed ID: 34028815
[TBL] [Abstract][Full Text] [Related]
2. The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
Jafarzadeh A; Jafarzadeh S; Sharifi I; Aminizadeh N; Nozari P; Nemati M
Cytokine; 2021 Nov; 147():155321. PubMed ID: 33039255
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
Katara GK; Ansari NA; Singh A; Ramesh V; Salotra P
PLoS Negl Trop Dis; 2012; 6(6):e1703. PubMed ID: 22724038
[TBL] [Abstract][Full Text] [Related]
4. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
5. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients.
Sarraf NR; Mukhopadhyay S; Banerjee A; Das AK; Roy S; Chakrabarti S; Manna M; Saha P
Acta Trop; 2021 Nov; 223():106086. PubMed ID: 34389331
[TBL] [Abstract][Full Text] [Related]
6. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
[TBL] [Abstract][Full Text] [Related]
7. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.
Ismail A; El Hassan AM; Kemp K; Gasim S; Kadaru AE; Moller T; Kharazmi A; Theander TG
J Pathol; 1999 Dec; 189(4):615-22. PubMed ID: 10629566
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
[TBL] [Abstract][Full Text] [Related]
9. Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S; Das NK; Barbhuiya JN; Chatterjee M
Int J Dermatol; 2010 Aug; 49(8):921-31. PubMed ID: 21128917
[TBL] [Abstract][Full Text] [Related]
10. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
[TBL] [Abstract][Full Text] [Related]
11. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
Zijlstra EE
Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
[TBL] [Abstract][Full Text] [Related]
12. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Sreenivas G; Raju BV; Singh R; Selvapandiyan A; Duncan R; Sarkar D; Nakhasi HL; Salotra P
J Clin Microbiol; 2004 Apr; 42(4):1739-41. PubMed ID: 15071036
[TBL] [Abstract][Full Text] [Related]
13. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis.
Gasim S; Elhassan AM; Khalil EA; Ismail A; Kadaru AM; Kharazmi A; Theander TG
Clin Exp Immunol; 1998 Jan; 111(1):64-9. PubMed ID: 9472662
[TBL] [Abstract][Full Text] [Related]
14. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
[TBL] [Abstract][Full Text] [Related]
15. Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis.
Salotra P; Raina A; Ramesh V
Trans R Soc Trop Med Hyg; 1999; 93(1):98-101. PubMed ID: 10492802
[TBL] [Abstract][Full Text] [Related]
16. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
[TBL] [Abstract][Full Text] [Related]
17. Indian erythrodermic postkala-azar dermal leishmaniasis.
Sethuraman G; Bhari N; Salotra P; Ramesh V
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28130283
[TBL] [Abstract][Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis: does it play a role in the transmission of Leishmania donovani in the Sudan?
El Hassan AM; Khalil EA
Trop Med Int Health; 2001 Sep; 6(9):743-4. PubMed ID: 11555443
[TBL] [Abstract][Full Text] [Related]
19. In-situ immune profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis.
Sengupta R; Mukherjee S; Moulik S; Mitra S; Chaudhuri SJ; Das NK; Chatterjee U; Chatterjee M
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():166-176. PubMed ID: 31542359
[TBL] [Abstract][Full Text] [Related]
20. Molecular Tracking of the
Moulik S; Sengupta S; Chatterjee M
Front Cell Infect Microbiol; 2021; 11():623437. PubMed ID: 33692966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
